Skip to main content
05_Bernardo_Franklin
© Photo: Bruna Guerra Photography

News categories: Honors & Funding

ERC Proof of Concept Grants for UNBIAS

European Research Council is supporting the journey from basic research to application

Prof. Bernardo Franklin from the Institute of Innate Immunity at the University Hospital Bonn has been awarded a Proof of Concept Grant by the European Research Council (ERC) as part of a program designed to help researchers translate their ideas from previous ERC projects into commercial applications. The project is awarded with a funding of €150,000, provided over a period of around one year.

ImmunoSensation2 member Prof. Dr. Bernardo S. Franklin studies hematopoietic stem cells (HSCs), which develop into different blood cells through processes of cell division and differentiation. “Bouts of inflammation that a person experiences as they get older will damage these stem cells,“ Bernardo S. Franklin says. “Processes like this cause hyperactivation of the innate immune system in the elderly.” This phenomenon, known as “inflammaging,” increases the risk of conditions including cardiovascular disease, diabetes and cancer, he adds.

“Wiping” the immune system’s harmful memories of inflammation


The project that has now secured ERC funding, which is entitled “Nanobodies to prevent hematopoietic stem cell bias and hyper-inflammation” (UNBIAS), aims to return HSCs to their original state in order to “wipe” the immune system’s harmful memories of inflammation. The researchers are using customized “mini-antibodies” known as nanobodies to achieve this. These antibodies, which are very small in relative terms, are taken from the blood of alpacas and can break up the places where inflammation develops.

Back in 2017, Franklin received a much-sought-after Starting Grant from the ERC worth some €1.5 million in funding. The Proof of Concept Grant will now build on this work already done. “Our aim is to validate the use of nanobodies to combat inflammaging and license this technology or its applications for industrial partners,” Franklin says. He believes that the project has the potential to alleviate the effects of inflammation and thus potentially save countless lives and the economic cost of illness.

Contact

Prof. Dr. Bernardo S. Franklin

Institute for Innate Immunity

University Hospital Bonn

Phone +49 228 28751981

Email: franklin@uni-bonn.de

Related news

With funding from the Corona Foundation, Dr Christina Mayer (right) is establishing her own junior research group and developing the field of neurovisual diagnostics at the Department of Neurology at UKB, headed by Prof Anne-Katrin Pröbstel (left).

News categories: Honors & Funding

The Retina as a Window into the Early Detection of Brain Diseases

—The retina is the only part of the central nervous system that can be examined non-invasively and at high resolution in living humans. Dr Christina Mayer and her team at Bonn University Hospital (UKB) and the University of Bonn aim to use this unique feature to detect inflammatory and vascular diseases of the brain earlier and more accurately, and to better understand how they develop. The Corona Foundation is providing €1 million to establish her junior research group. The programme gives outstanding early-career researchers the opportunity to qualify for a university professorship.
View entry
Prof. Joanna Kalucka joins Bonn as a Mercator Fellow and investigates how metabolic and inflammatory processes affect the inner lining of blood vessels.

News categories: Honors & Funding

Joanna Kalucka Joins Bonn as a Mercator Fellow

—Joanna Kalucka, Associate Professor at Aarhus University’s Department of Biomedicine, will join the Collaborative Research Centre (CRC) 1454 “Metaflammation and Cellular Programming” at the University of Bonn and Bonn University Hospital (UKB) as a Mercator Fellow Global from 2027. The German Research Foundation (DFG) is funding her fellowship through the “1000 Heads Plus” programme of the Federal Ministry of Research, Technology and Space (BMFTR).
View entry
Prof. Christian Henneberger, Direktor des Instituts für Zelluläre Neurowissenschaften I am UKB, und Prof. Susanne Schoch McGovern,
Prof. Christian Henneberger, Direktor des Instituts für Zelluläre Neurowissenschaften I am UKB, und Prof. Susanne Schoch McGovern, - Direktorin des Instituts für Zelluläre Neurowissenschaften II am UKB, sind Sprecher und stellvertretende Sprecherin der neuen DFG-Forschungsgruppe FOR 5987. Der Forschungsverbund untersucht, wie Botenstoffe Informationen im Gehirn innerhalb und außerhalb von Synapsen übertragen.

News categories: Honors & Funding

How Far Do Signalling Molecules Act Beyond the Boundaries of a Synapse?

—The German Research Foundation (DFG) is establishing a new Research Unit entitled “Inside and Outside the Synapse: Challenging Dogmas of Synaptic Signalling and Neuromodulation.” The research consortium is headed by Prof. Christian Henneberger from Bonn University Hospital (UKB) and the University of Bonn, with Prof. Susanne Schoch McGovern, also from the UKB and the University of Bonn. Together with researchers from the UKB, the University of Bonn, the DZNE and the University of Göttingen, they will investigate how signalling molecules transmit information in the brain.
View entry

Back to the news overview